$202 Million is the total value of First Light Asset Management, LLC's 62 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 15.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ATRC | Buy | ATRICURE INCcs | $19,705,000 | +3.5% | 899,362 | +16.4% | 9.73% | +8.6% |
| NEO | Buy | NEOGENOMICS INCcs | $17,027,000 | +15.0% | 2,971,545 | +8.5% | 8.41% | +20.7% |
| RTIX | Buy | RTI BIOLOGICS INCcs | $11,338,000 | +2.4% | 1,996,191 | +16.5% | 5.60% | +7.5% |
| AKRXQ | Buy | AKORN INCcs | $9,249,000 | -24.4% | 324,480 | +15.8% | 4.57% | -20.6% |
| TEAR | Buy | TEARLAB CORPcs | $7,566,000 | +24.1% | 3,764,165 | +24.7% | 3.74% | +30.3% |
| HBIO | Buy | HARVARD BIOSCIENCE INCcs | $7,493,000 | -23.0% | 1,982,194 | +16.1% | 3.70% | -19.2% |
| ENZ | Buy | ENZO BIOCHEM INCcs | $7,056,000 | +61.8% | 2,226,001 | +54.7% | 3.49% | +69.9% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLCcs | $7,030,000 | +13.2% | 520,755 | +16.1% | 3.47% | +18.9% |
| LHCG | Buy | LHC GROUP INCcs | $6,825,000 | +35.7% | 152,441 | +16.0% | 3.37% | +42.5% |
| IG | Buy | IGI INCcs | $6,613,000 | +19.2% | 1,011,217 | +14.8% | 3.27% | +25.1% |
| OMCL | Buy | OMNICELL INCcs | $5,363,000 | -3.2% | 172,429 | +17.4% | 2.65% | +1.6% |
| INSM | Buy | INSMED INCcs | $5,058,000 | -10.5% | 272,393 | +17.7% | 2.50% | -6.1% |
| TECH | Buy | BIO TECHNE CORPcs | $5,019,000 | +8.6% | 54,286 | +15.7% | 2.48% | +14.0% |
| LGND | Buy | LIGAND PHARMACEUTICALS INCcs | $4,931,000 | -0.5% | 57,571 | +17.2% | 2.44% | +4.5% |
| CYNA | Buy | CYNAPSUS THERAPEUTICS INCcs | $4,886,000 | +16.0% | 302,194 | +16.9% | 2.41% | +21.7% |
| DOC | New | PHYSICIANS RLTY TRcs | $4,859,000 | – | 321,979 | +100.0% | 2.40% | – |
| LMAT | Buy | LEMAITRE VASCULAR INCcs | $4,586,000 | +18.6% | 376,211 | +17.3% | 2.26% | +24.5% |
| ARRY | Buy | ARRAY BIOPHARMA INCcs | $4,508,000 | -26.4% | 988,589 | +16.4% | 2.23% | -22.7% |
| ENTL | New | ENTELLUS MED INCcs | $4,370,000 | – | 242,532 | +100.0% | 2.16% | – |
| QDEL | Buy | QUIDEL CORPcs | $3,796,000 | -4.2% | 201,067 | +16.4% | 1.88% | +0.5% |
| ALKS | Buy | ALKERMES PLCcs | $3,764,000 | +7.3% | 64,148 | +17.6% | 1.86% | +12.6% |
| ANGO | Buy | ANGIODYNAMICS INCcs | $3,658,000 | -5.8% | 277,323 | +17.2% | 1.81% | -1.1% |
| SPNC | Buy | SPECTRANETICS CORPcs | $3,367,000 | -41.3% | 285,596 | +14.6% | 1.66% | -38.4% |
| MDCO | New | MEDICINES COcs | $3,193,000 | – | 84,103 | +100.0% | 1.58% | – |
| CPHD | Buy | CEPHEIDcs | $2,905,000 | -13.1% | 64,271 | +17.5% | 1.44% | -8.8% |
| STRM | Buy | STREAMLINE HEALTH SOLUTIONScs | $2,874,000 | -5.6% | 1,255,148 | +15.4% | 1.42% | -0.9% |
| ARWR | New | ARROWHEAD RESH CORPcs | $2,681,000 | – | 465,503 | +100.0% | 1.32% | – |
| VCYT | Buy | VERACYTE INCcs | $2,650,000 | -50.7% | 564,932 | +17.1% | 1.31% | -48.2% |
| HSTM | Buy | HEALTHSTREAM INCcs | $2,581,000 | -15.8% | 118,352 | +17.5% | 1.28% | -11.6% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INCcs | $2,566,000 | -1.5% | 24,643 | +16.8% | 1.27% | +3.4% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEWcs | $2,268,000 | -51.5% | 215,137 | +16.1% | 1.12% | -49.1% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INCcs | $2,017,000 | -9.9% | 19,153 | +17.0% | 1.00% | -5.4% |
| KPTI | New | KARYOPHARM THERAPEUTICS INCcs | $1,629,000 | – | 154,710 | +100.0% | 0.80% | – |
| BLUE | Buy | BLUEBIRD BIO INCcs | $1,165,000 | -40.4% | 13,623 | +17.3% | 0.58% | -37.4% |
| ESPR | Buy | ESPERION THERAPEUTICS INC NEcs | $1,131,000 | -30.6% | 47,965 | +140.7% | 0.56% | -27.1% |
| PETX | Buy | ARATANA THERAPEUTICS INCcs | $701,000 | -34.4% | 82,911 | +17.4% | 0.35% | -31.2% |
| AZN | Buy | ASTRAZENECA PLCadr | $361,000 | -0.3% | 11,360 | +100.0% | 0.18% | +4.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-11-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 43 | Q2 2024 | 9.7% |
| NEOGENOMICS INC | 43 | Q2 2024 | 10.6% |
| SANOFI-SYNTHELABO | 41 | Q4 2023 | 1.9% |
| JOHNSON & JOHNSON | 41 | Q4 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 37 | Q4 2023 | 1.6% |
| NOVARTIS AG-SPONSORED ADR | 34 | Q4 2023 | 0.4% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| MODEL N INC | 32 | Q1 2024 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| OptimizeRx Corp | June 10, 2024 | 1,829,074 | 10.0% |
| TELA Bio, Inc.Sold out | June 10, 2024 | 0 | 0.0% |
| Societal CDMO, Inc. | April 09, 2024 | ? | ? |
| KORU Medical Systems, Inc. | February 14, 2024 | 5,158,444 | 11.3% |
| Performant Financial Corp | February 14, 2024 | 9,696,781 | 12.6% |
| PLIANT THERAPEUTICS, INC. | February 14, 2024 | 3,634,510 | 6.1% |
| SI-BONE, Inc. | February 14, 2024 | 2,532,227 | 6.2% |
| Sonendo, Inc. | February 14, 2024 | 5,446,491 | 10.0% |
| Miromatrix Medical Inc. | December 07, 2023 | 2,592,022 | 9.4% |
| Orthofix Medical Inc.Sold out | October 30, 2023 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-15 |
| 13F-HR | 2024-08-14 |
| SC 13G | 2024-08-09 |
| SC 13G/A | 2024-07-10 |
| SC 13G/A | 2024-06-10 |
| SC 13G/A | 2024-06-10 |
| 13F-HR | 2024-05-15 |
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.